서브메뉴
검색
The Medication Experience of African-American Women Living With Kidney-Related Diseases: A Phenomenological Inquiry- [electronic resource]
The Medication Experience of African-American Women Living With Kidney-Related Diseases: A Phenomenological Inquiry- [electronic resource]
상세정보
- 자료유형
- 학위논문
- Control Number
- 0016934222
- International Standard Book Number
- 9798380125468
- Dewey Decimal Classification Number
- 614
- Main Entry-Personal Name
- Ann Hillman, Lisa.
- Publication, Distribution, etc. (Imprint
- [S.l.] : University of Minnesota., 2023
- Publication, Distribution, etc. (Imprint
- Ann Arbor : ProQuest Dissertations & Theses, 2023
- Physical Description
- 1 online resource(258 p.)
- General Note
- Source: Dissertations Abstracts International, Volume: 85-02, Section: B.
- General Note
- Advisor: Schommer, Jon C.;Ramalho de Oliveira, Djenane.
- Dissertation Note
- Thesis (Ph.D.)--University of Minnesota, 2023.
- Restrictions on Access Note
- This item must not be sold to any third party vendors.
- Summary, Etc.
- 요약Chronic kidney disease affects 37 million Americans (14.0%), results in poor quality of life and mortality, is costly for the US Healthcare system and disproportionately impacts Black Americans. The optimal time to intervene in the course of chronic kidney disease is early, making treatment of the disease and risk factors, often with medications, a priority. The African-American woman's lived experience lies at the intersection of race, gender, and other relevant social factors impacting medication use. Knowledge of the experience of medication taking of these women in the context of their everyday lives may shed meaningful insight into person-centered interventions aimed to improve patients' use and experience with medications. Objectives are (1) Explore the medication experiences of African-American women taking medications for chronic diseases related to chronic kidney disease, and (2) Reveal individuals' prioritization of medication-related decisions in the context of their everyday lives. A phenomenological approach was undertaken. One-on-one interviews were conducted with seventeen African-American adult women taking at least one medication for chronic kidney disease or a chronic disease that places them at high risk (hypertension or diabetes mellitus) for chronic kidney disease. The existential structures of the lifeworld as described by French Philosopher Merleau-Ponty were used to guide thematic analysis of data and was based in traditions of phenomenology. Five themes of (1) guided by a personal agency with medications, (2) sense of personal duty to care for self and others, (3) making sense of the body and self with medications, (4) staying on track with medications and with life, and (5) desire to living freely with medications and from their constraints are described. Priorities with medication taking behaviors in daily living experience were revealed to be: (1) safety and security, (2) singularity of experience, and (3) autonomy and vitality. Patient-centered care needs to consider the patient and their medication taking from the perspective of their priorities and daily living. Health care professionals need to practice self-awareness and listen attentively to understand the experiences their patients have with their medications. Knowledge of the medication experience can then inform strategies and interventions that are meaningful to patients.
- Subject Added Entry-Topical Term
- Pharmaceutical sciences.
- Subject Added Entry-Topical Term
- Health sciences.
- Subject Added Entry-Topical Term
- Social research.
- Index Term-Uncontrolled
- African-American women
- Index Term-Uncontrolled
- Kidney disease
- Index Term-Uncontrolled
- Lived experience
- Index Term-Uncontrolled
- Medication experience
- Index Term-Uncontrolled
- Pharmacist
- Index Term-Uncontrolled
- Phenomenology
- Added Entry-Corporate Name
- University of Minnesota Social and Administrative Pharmacy
- Host Item Entry
- Dissertations Abstracts International. 85-02B.
- Host Item Entry
- Dissertation Abstract International
- Electronic Location and Access
- 로그인을 한후 보실 수 있는 자료입니다.
- Control Number
- joongbu:641553
MARC
008240221s2023 ulk 00 kor■001000016934222
■00520240214101544
■006m o d
■007cr#unu||||||||
■020 ▼a9798380125468
■035 ▼a(MiAaPQ)AAI30573362
■040 ▼aMiAaPQ▼cMiAaPQ
■0820 ▼a614
■1001 ▼aAnn Hillman, Lisa.
■24510▼aThe Medication Experience of African-American Women Living With Kidney-Related Diseases: A Phenomenological Inquiry▼h[electronic resource]
■260 ▼a[S.l.]▼bUniversity of Minnesota. ▼c2023
■260 1▼aAnn Arbor▼bProQuest Dissertations & Theses▼c2023
■300 ▼a1 online resource(258 p.)
■500 ▼aSource: Dissertations Abstracts International, Volume: 85-02, Section: B.
■500 ▼aAdvisor: Schommer, Jon C.;Ramalho de Oliveira, Djenane.
■5021 ▼aThesis (Ph.D.)--University of Minnesota, 2023.
■506 ▼aThis item must not be sold to any third party vendors.
■520 ▼aChronic kidney disease affects 37 million Americans (14.0%), results in poor quality of life and mortality, is costly for the US Healthcare system and disproportionately impacts Black Americans. The optimal time to intervene in the course of chronic kidney disease is early, making treatment of the disease and risk factors, often with medications, a priority. The African-American woman's lived experience lies at the intersection of race, gender, and other relevant social factors impacting medication use. Knowledge of the experience of medication taking of these women in the context of their everyday lives may shed meaningful insight into person-centered interventions aimed to improve patients' use and experience with medications. Objectives are (1) Explore the medication experiences of African-American women taking medications for chronic diseases related to chronic kidney disease, and (2) Reveal individuals' prioritization of medication-related decisions in the context of their everyday lives. A phenomenological approach was undertaken. One-on-one interviews were conducted with seventeen African-American adult women taking at least one medication for chronic kidney disease or a chronic disease that places them at high risk (hypertension or diabetes mellitus) for chronic kidney disease. The existential structures of the lifeworld as described by French Philosopher Merleau-Ponty were used to guide thematic analysis of data and was based in traditions of phenomenology. Five themes of (1) guided by a personal agency with medications, (2) sense of personal duty to care for self and others, (3) making sense of the body and self with medications, (4) staying on track with medications and with life, and (5) desire to living freely with medications and from their constraints are described. Priorities with medication taking behaviors in daily living experience were revealed to be: (1) safety and security, (2) singularity of experience, and (3) autonomy and vitality. Patient-centered care needs to consider the patient and their medication taking from the perspective of their priorities and daily living. Health care professionals need to practice self-awareness and listen attentively to understand the experiences their patients have with their medications. Knowledge of the medication experience can then inform strategies and interventions that are meaningful to patients.
■590 ▼aSchool code: 0130.
■650 4▼aPharmaceutical sciences.
■650 4▼aHealth sciences.
■650 4▼aSocial research.
■653 ▼aAfrican-American women
■653 ▼aKidney disease
■653 ▼aLived experience
■653 ▼aMedication experience
■653 ▼aPharmacist
■653 ▼aPhenomenology
■690 ▼a0572
■690 ▼a0566
■690 ▼a0344
■71020▼aUniversity of Minnesota▼bSocial and Administrative Pharmacy.
■7730 ▼tDissertations Abstracts International▼g85-02B.
■773 ▼tDissertation Abstract International
■790 ▼a0130
■791 ▼aPh.D.
■792 ▼a2023
■793 ▼aEnglish
■85640▼uhttp://www.riss.kr/pdu/ddodLink.do?id=T16934222▼nKERIS▼z이 자료의 원문은 한국교육학술정보원에서 제공합니다.
■980 ▼a202402▼f2024
